Holocene Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,126
Closed -$927K 861
2025
Q4
$927K Sell
9,126
-2,716,264
-100% -$218M ﹤0.01% 608
2025
Q3
$149M Buy
2,725,390
+580,209
+27% +$29M 0.34% 69
2025
Q2
$114M Buy
2,145,181
+1,404,086
+189% +$71.3M 0.28% 97
2025
Q1
$32.1M Sell
741,095
-156,437
-17% -$7.92M 0.09% 204
2024
Q4
$50.4M Sell
897,532
-971,895
-52% -$60.5M 0.16% 164
2024
Q3
$127M Sell
1,869,427
-2,169,207
-54% -$122M 0.51% 56
2024
Q2
$171M Buy
4,038,634
+1,540,261
+62% +$84.7M 0.71% 36
2024
Q1
$173M Buy
2,498,373
+2,120,023
+560% +$134M 0.63% 50
2023
Q4
$28M Buy
378,350
+315,428
+501% +$20.7M 0.11% 194
2023
Q3
$4.29M Buy
62,922
+14,571
+30% +$1.24M 0.02% 417
2023
Q2
$4.54M Buy
+48,351
New +$3.77M 0.02% 372

Other funds holding EXAS

Holocene Advisors's EXAS Position: Q1 2026 in Review

Holocene Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,126 shares — an estimated $927K sold.

Holocene Advisors first reported a position in EXAS in Q2 2023 and held it in 11 quarters. The position peaked at $173M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Holocene Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 9,126 Exact Sciences shares in Q1 2026, an estimated $927K.
  • Holocene Advisors first reported a position in Exact Sciences in Q2 2023 and held it in 11 quarters.
  • Holocene Advisors's Exact Sciences position peaked at $173M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.